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Remodeling of the actin cytoskeleton through actin dynamics is involved in a number of biological processes, but
its role in human stromal (skeletal) stem cells (hMSCs) differentiation is poorly understood. In the present study,
we demonstrated that stabilizing actin ﬁlaments by inhibiting gene expression of the two main actin
depolymerizing factors (ADFs): Coﬁlin 1 (CFL1) and Destrin (DSTN) in hMSCs, enhanced cell viability and differ-
entiation into osteoblastic cells (OB) in vitro, as well as heterotopic bone formation in vivo. Similarly, treating
hMSC with Phalloidin, which is known to stabilize polymerized actin ﬁlaments, increased hMSCs viability and
OB differentiation. Conversely, Cytocholasin D, an inhibitor of actin polymerization, reduced cell viability and
inhibited OB differentiation of hMSC. At amolecular level, preventing Coﬁlin phosphorylation through inhibition
of LIM domain kinase 1 (LIMK1) decreased cell viability and impaired OB differentiation of hMSCs. Moreover,
depolymerizing actin reduced FAK, p38 and JNK activation during OB differentiation of hMSCs, while polymeriz-
ing actin enhanced these signaling pathways. Our results demonstrate that the actin dynamic reassembly and
Coﬁlin phosphorylation loop is involved in the control of hMSC proliferation and osteoblasts differentiation.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Cytoskeleton is a cellular scaffolding contained within cytoplasm. It
maintains the cell shape, provides mechanical strength, directs locomo-
tion, regulates chromosome separation in mitosis and meiosis and intra-
cellular transport of organelles in cells (Doherty and McMahon, 2008;
Van Troys et al., 2008). Actin microﬁlaments are the major structure of
the cytoskeleton. The actin protein exists within cells in either globular/
monomer (G-actin) or ﬁlamentous (F-actin) forms and thus in highly
dynamic transitions of depolymerization and polymerizationin. During
depolymerization, polymerized actin (F-actin) is severed/depolymerized
and turns to monomer actin (G-actin). G-actin can be recycled, trans-
ferred back intoﬁlament formby anADP-to-ATP exchange. ATP-actin be-
comes available for assembly and polymerization to F-actin (Ono, 2007).
The process of assembly and disassembly of actin ﬁlaments in cells is
regulated by actin depolymerizing factors (ADFs) that in mammals
include: Coﬁlin1 (CFL1, non-muscle Coﬁlin), Coﬁlin2 (CFL2, muscle
Coﬁlin), andDestrin (DSTN, also called ADF or Corn1). CFL1 is ubiquitous-
ly expressed, while CFL2 is only expressed inmuscles. DSTN also exhibits
ubiquitous expression, and its levels are about 5% to 10% of CFL1 levels
(Vartiainen et al., 2002). Coﬁlin binds to actin monomers and ﬁlaments,
causing depolymerization of actin ﬁlaments preventing their reassembly
(Ghosh et al., 2004). Phosphorylation and dephosphorylation regulate
Coﬁlin’s binding and associating activity with actin (Lappalainen and
Drubin, 1997; Maekawa et al., 1999). DSTN is a component protein in
microﬁlaments. It severs actin ﬁlaments (F-actin) and binds to G-actin,
thereby, sequestering actin monomers and preventing polymerization
(Hawkins et al., 1993).
During lineage speciﬁc differentiation, human stromal (skeletal)
stem cells (hMSCs) exhibit signiﬁcant changes in morphology and
actin cytoskeletal organization (McBeath et al., 2004; Yourek et al.,
2007; Treiser et al., 2010). For example, during adipocyte differentia-
tion, the cells undergo a morphological change from ﬁbroblastic to
spherical cells ﬁlled with lipid droplets (Fan et al., 1983). The change
in cell shape takes place early in the differentiation process prior to
the up-regulation of many adipocyte speciﬁc genes and in association
with cytoskeletal changes including decreased actin synthesis and
actin reorganization (Antras et al., 1989). Altered actin organization
inﬂuences cytoskeletal tension which has been demonstrated to play a
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role in adipogenesis in cultured MSCs (McBeath et al., 2004). Similarly,
during chondrocyte differentiation of hMSCs, signiﬁcant changes in
cell shape that transform from a ﬁbroblast-like to a circularmorphology
leading to a signiﬁcant increase in cell volume (Xu et al., 2008). Similar-
ly, the regulatory role of actin dynamics in chondrocyte differentiation
has been supported by a number of experiments. Actin-disrupting com-
pounds, such as cytochalasin D, stimulate chondrogenesis (Loty et al.,
1995). In addition, intracellular kinases induced by adhesion signaling
from extracellular matrix (ECM) proteins, regulate chondrocyte differ-
entiation through changes in actin cytoskeleton (Woods et al., 2005,
2007; Nurminsky et al., 2007).
We became interested in the potential role of ADF genes and actin
dynamics during osteoblast (OB) differentiation of hMSCs for several
reasons. First, actin and microtubules are abundant in osteoblasts
(Aubin et al., 1983; Arena et al., 1991). During OB differentiation, cell
morphology is found to alter from ﬁbroblast-like to cuboidalmorpholo-
gy; this is accompanied by changes in actin cytoskeleton (Lomri et al.,
1987). Second, bone is a tissue that is sensitive to mechanical stimula-
tion. The responses of osteoblastic cells to the appliedmechanical forces
are transmitted through plasmamembrane adhesion molecules and in-
duce alterations in actin cytoskeletal organization (Sakai et al., 2011).
Third, some studies have reported that the upstream regulator of
ADFs, such as Rho GTPase/Rho-Associated kinase (Rock), extracellular
matrix (ECM) components, and adhesion kinases, act as regulators for
OB differentiation (Harmey et al., 2004; Hamidouche et al., 2009;
Mathews et al., 2012). However, evidence for the direct role of ADFs
and dynamic organization of actin in MSCs biology and OB differentia-
tion are not clear (Kawano et al., 2013; Shuang et al., 2013).
Thus, we examined the regulatory role of ADFs and actin cytoskeletal
changes on lineage speciﬁc differentiation of hMSCs. We demonstrated
that G-actin (monomer) and F-actin (polymerized) ratio was altered
after induction of OB differentiation of hMSCs and was associated with
signiﬁcant changes in expression of ADFs. Lowering the expression
levels of ADFs enhanced the polymerization of actin ﬁlaments,
enhanced cell viability, and OB differentiation of hMSCs.
2. Materials and methods
2.1. Cell culture and OB differentiation of hMSCs
Primary hMSCs were isolated from human bonemarrow aspirate as
described previously (Stenderup et al., 2004). As a model for primary
hMSCs, we employed the hMSC-TERT cell created in our laboratory by
overexpression of human telomerase reverse transcriptase (hTERT)
gene (Simonsen et al., 2002). hMSC-TERT exhibits all the characteristics
of primary MSC in vitro and form normal heterotopic bone when
implanted in vivo (Simonsen et al., 2002). Cells were grown in Minimal
Essential Media (MEM) without Phenol red and L-glutamine,
supplemented with 10% (v/v) fetal bovine serum (FBS), 2 mM
Glutamax, 100 units/ml penicillin, and 100 μg/ml streptomycin
(Gibco-Invitrogen, Carlsbad, CA), referred to as standard growth
medium. In vitroOBdifferentiation of hMSCwas carried out usingOB in-
duction medium containing standard growth medium supplemented
with 10-8 M dexamethasone, 0.2 mM L-ascorbic acid, 10 mM β-
glycerophosphate (Sigma), and 10 mM 1.25-vitamin-D3 (Leo®
pharma).
2.2. Alkaline phosphatase (ALP) and Alizarin red S (AZR) staining
ALP cytochemical staining was performed on cultured cells by rins-
ing the cell layer with PBS followed by ﬁxation in acetone/citrate
(1.5:1, v:v) buffer (pH 4.2) for 5 minutes at room temperature. The
cells were incubated with buffer containing 0.2 mg/ml naphthol AS-TR
phosphate (Sigma). After incubation for one hour at 37 °C, the cell
layer was washed with deionized water. Alizarin red S staining was
employed to assess the presence of in vitro formed mineralized matrix.
The medium was removed, and the cell layer was rinsed with PBS and
ﬁxed in 70% ethanol for 1 hour at -20 °C. The cell layer was washed
with deionized water. The ﬁxed cells were stained with 40 mMAlizarin
red S pH 4.2 (Sigma) for 10minutes at room temperature. The cell layer
was washed with deionized water. For quantitative assessment of the
degree of mineralization, the color was eluted by 10% (wt/vol)
cetylpyridinium chloride (Sigma) for 1 h and quantiﬁed by spectropho-
tometric absorbancemeasurements at OD570nm (Gregory et al., 2004).
2.3. ALP activity assay
ALP activity assay was performed in the96-well plate. Cell number
(i.e. the number of viable cells) was determined by adding the
CellTiter-Blue solution (Promega) for 1 hour andmeasured the ﬂuores-
cence at wavelength of 579Ex/584Em. The cells were then rinsed with
PBS and ﬁxed in 3.7% formaldehyde-90% ethanol for 30 seconds at
room temperature. A reaction mixture containing 100 μl 50 mM
NaHCO3, 1mMMgCl2 (Sigma) and 1mg/ml of p-nitrophenyl phosphate
(Sigma)was added into eachwell and incubated at 37 °C for 20minutes.
The reactionwas stopped by adding 50 μl of 3MNaOH. Absorbancewas
determined at 405 nm in an ELISA microplate reader. ALP enzymatic
activity was normalized to cell number in each well.
2.4. Cell transfection
Small interfering RNA (siRNA) duplex oligos targeting DSTN, CFL1,
CFL2, LIMK1, as well as non-targeting duplex oligo (siRNA negative
controls)were purchased fromAmbion (Life Technology Inc.). These re-
agents were transfected into hMSC-TERT at a ﬁnal concentration of 12
nM for siRNA. All transfections were performed using Lipofecta-
mine2000 Transfection Reagent (Invitrogen), according to themanufac-
turer’s instructions.
2.5. Treatment with Cytochalasin D and Phalloidin during OB differentiation
in hMSCs
hMSCswere seeded in 24-well plate or 96-well plate and induced to
osteogenic differentiation as described above. The media was changed
every third day. Before media change, the cells were pre-treated with
Cytochalstin D (Sigma, C8273) (1-20 uM) for 1 h or Phalloidin (Sigma,
P2141) (0-6 uM) for 3 h. After treatment, cells were washed and incu-
bated in differentiation medium. Equal volumes of DMSO solution was
added into the corresponding controls wells.
2.6. Actin staining and cell shape detection by high content cellomic
analysis
Cells were seeded at a density of 2000 cells perwell into clear bottom
96-well CellCarrier™ microtiter plates (PerkinElmer), the Operetta®
High Content Imaging System was used to study the cellular changes.
Cells were washed with PBS, ﬁxed with 4% formaldehyde for 30 min,
and permeabilized with 0.1% Triton™-X-100 for 10 min. Subsequently,
the cells were stained with a dye solution containing 10 μg/mL
4',6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich®, D8417)
and 5 μg/mL Phalloidin-TRITC (Sigma-Aldrich®, P1951). Images were
acquired on an Operetta® high content image System (Perkin Elmer)
using a 10X high NA (numerical apertures) objective in wide-ﬁeld
mode. All pictureswere acquiredwith the same contrast and brightness
parameters. For quantitative analyses, individual cells were segmented
based on the DAPI nuclear stain using the Find Nuclei building block in
the Harmony® High Content Imaging and Analysis Software. The fol-
lowing parameters were determined per cell: cell size (area) (μm2),
cell length (μm), cell width (μm), cell roundness, cell ratio (width to
length), nuclear size (μm2), and nuclear roundness. The staining inten-
sity of TRITC was measured in each well and normalized to the cell
number.
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2.7. G-actin/F-actin assay
The ﬁlamentous (F-actin) andmonomer actin (G-actin) in cells were
quantitated by G-actin/F-actin in vivo assay kit as manufacturer’s in-
structions (Cytoskeleton Inc.). Cells were harvested by scraping in
lysis and F-actin stabilization buffer. The homogenates were incubated
at 37 °C for 10 mins, transferred to a pre-warmed (37 °C), ultracentri-
fuge (SORVALL/Thermo Scientiﬁc), and spun at 100,000 g for 1 h at
37 °C to separate the globular (G)-actin (supernatant) and ﬁlamentous
(F)-actin fractions (pellet). The pellets were re-suspended in ice-cold
depolymeraizing buffer. All samples were diluted with the appropriate
loading buffer and boiled for 5min. The samples were further separated
by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) and Western blot analysis. The blots were scanned and the
protein bands were subjected to intensity quantiﬁcation in ImageJ®
software. The ratios of F-actin or G-actin in cells were calculated
according to the density.
2.8. Western blot analysis
hMSC cells werewashed in PBS and lysed in RIPA buffer (Invitrogen)
supplemented with protease inhibitors (Roche). After 1 h incubation at
4 °C, samples were centrifuged for 10min at 12,000 rpm at 4 °C. Protein
concentration was determined with Pierce CoomassiePlus Bradford
assay (Thermo Fisher Scientiﬁc), and equal amounts of protein were
loaded on a 10% polyacrylamide gel (Invitrogen). Blotted nitrocellulose
membranes were incubated with antibodies overnight at 4 °C. Mem-
branes were incubated with HRP conjugated anti-mouse or anti-rabbit
secondary antibody (Santa Cruz Biotechnology) for 45 min at room
temperature. The protein bands were visualized with Amersham ECL
chemiluminescence detection system (GE Healthcare Bio-Sciences
Corp) in X-ray ﬁlms. Results were scanned and edited in Photoshop®.
Antibodies (total or phosphor) speciﬁc for AKT, SMAD1/5/8, ERK,
RUNX2 and LIMK1 were obtained from Cell Signaling Technology®.
Antibodies for phos-CFL1, total CFL1 were purchased from Abcam®.
Antibodies for DSTN and α-tubulin were bought from Sigma®. The
antibody for actin was bought with G-actin/F-actin in vivo assay kit
(Cytoskeleton Inc.). All antibodies were used at 1:1000 dilutions except
α-tubulin antibody (1:5000) in this study.
2.9. Quantitative real-time reverse transcription polymerase chain reaction
(qRT-PCR)
For gene expression, total RNA was extracted with TriZoL reagent
(Invitrogen), and cDNA was prepared using revert Aid H minus ﬁrst
strand cDNA synthesis kit (Fermentas). The primers that were
employed are listed in Table S1. The PCR products were visualized in
real-time using SYBR Green I Supermix (Bio-Rad) and an iCycle instru-
ment (Bio-Rad) using standard curve protocols normalized to beta-2-
microglobulin (B2m). The quantitative data presented are an average
of duplicate or triplicate per independent experiment.
2.10. In vivo heterotopic bone formation assay
hMSC (5 × 105cells/sample) were loaded on 40 mg wet
hydroxyapatite/tricalcium phosphate (HA/TCP) (Zimmer), incubated
at 37 °C overnight, and implanted subcutaneously on the dorsal side
of 8-week-old NOD.CB17-Prkdcscid/J mice (NOD/SCID) as previously
described (Stenderup et al., 2004; Abdallah et al., 2008). Implants
were removed after 8 weeks, ﬁxed in 4% paraformaldehyde, decalciﬁed
in formic acid, and embedded in parafﬁn. Sections (4-μm) were cut
and stained with eosin/hematoxlyin (Bie&Berntsens, Denmark). Bone
volume per total volume was quantiﬁed as previously described
(Abdallah et al., 2008). All animal experiments were carried out in
accordance with permissions issued by The Animal Experiments
Inspectorate.
2.11. Statistical analysis
Data are presented as mean ± standard error of the mean (SEM).
Statistical testing was performed using Student's t-test to detect
differences between groups. Differences were considered statistically
signiﬁcant at P b 0.05 (*), P b 0.001 (**).
3. Results
3.1. Changes in cytoskeletal proteins expression during osteoblast (OB)
differentiation of hMSCs
We observed an association of changes in actin forms and expres-
sions of ADFs during in vitro OB differentiation of hMSCs. In undifferen-
tiated hMSCs, we measured that 46% of actin is soluble (G-actin) and
54% is polymeric (F-actin). During the initial differentiation, until
day 3, there was a decrease of F-actin (to around 40%) and increase of
G-actin (up to around 60%). Following OB differentiation induction,
we observed a gradual increase in polymeric actin (F-actin) that
reached maximal levels on day 13 (F-actin, 63%) (Fig. 1A). The change
in actin forms during OB differentiation was associated with changes
in the expression levels of key ADFs. Levels of total CFL1 remained
stable throughout the differentiation process, but levels of phosphory-
lated (P-) CFL1 (inactive form)were increased. Conversely, DSTN levels
increased at the beginning of differentiation anddecreased following in-
duction of OB differentiation. The LIMK1 phosphorylation increased
during OB differentiation, while the total LIMK1 was unchanged
(Fig. 1B).
3.2. siRNA-mediated knock-down of Coﬁlin and Destrin expression
enhanced OB differentiation of hMSCs in vitro and heterotopic bone
formation in vivo
In order to detect the role of ADFs and actin dynamics in OB differen-
tiation, we employed siRNA-mediated knock down of the two key ADFs
and examined the effects on OB differentiation of hMSCs. Knock down
of CFL1 or DSTN in hMSCs blocked the protein expression in cells
(around 95%, see Fig. S1 for real time PCR and Western blot analysis).
Knocking down of CFL1 and DSTN both increased viable cell numbers
on day 7 of OB differentiation, and decreasing DSTN has signiﬁcant
Fig. 1.Changes inmonomeric (G-actin), polymeric actin (F-actin) and actin depolymerizing
factors (ADFs) during OB differentiation in hMSCs. Human stromal (skeletal) stem cells
(hMSCs) were induced to osteoblast (OB) differentiation as evidenced by positive
cytochemical staining of alkaline phosphatase (ALP) and Alizarin red (AZR) presented as
scanned pictures of culture dishes (B). Protein samples were harvested at differentiation
day 0, 3, 7, 10 and 13. A) Actins were separated by ultracentrifugation to F-actin and
G-actin and subjected to Western Blot analysis (upper part) for quantitation of the ratio
of F-actin and G-actin in cells (lower part). D: Days after differentiation induction.
B) Total cell lysates were subjected to Western blot analysis of ADFs and LIMK1. Alpha-
tubulin was measured as protein loading control. Results show the representational data
derived from at least three independent experiments.
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effect (Fig. 2A & Fig. S2C). siRNA-mediated knockdown of CFL1 en-
hanced OB differentiation of hMSCs evidenced by signiﬁcant increase
in ALP staining at day 7 (Fig. 2B) and mineralized matrix formation at
day 10 (Fig. 2C) of OB differentiation. For DSTN, the effects of knock
down were more pronounced on mineralized matrix formation
(Fig. 2C). Similar results were observed upon siRNA-mediated knock
down of CFL1 and DSTN in human bone marrow derived primary MSC
(Fig. S2). Interestingly, knocking down of CFL2, a muscle speciﬁc ADF,
did not lead to detectable effects on OB differentiation (Fig. S3).
To investigate the function of ADFs on bone formation, hMSCs
transfected with siRNA against CFL1 and DSTN or corresponding non-
target controls, were implanted subcutaneously into immune deﬁcient
mice. Heterotopic bone formation was signiﬁcantly increased (more
than 1.5 times) in implants of hMSCs deﬁcient in CFL1 or DSTN
compared with control (Fig. 2D, E).
3.3. siRNA-mediated knockdown of CFL1 and DSTN increased polymerized
actin (F-actin) and not change cell morphology of hMSCs
To further detect the effects of siRNA-mediated knock down of CFL1
and DSTN on actin dynamics, we stained cells by TRITC-coupled
Phalloidin that binds polymerized actin ﬁlaments (F-actin). We exam-
ined the morphological changes in the cells using high content imaging
(Fig. 3A). NKnockdown of CFL1 or DSTN did not affect cellular morphol-
ogy i.e. nuclear size, nuclear roundness, cell size, cell width, cell length,
ratio of cell width to length, and cell roundness (Fig. 3B).We detected a
signiﬁcant increase in the intensity of TRITC-Phalloidin staining (Fig. 3C)
suggesting increased polymerized actin ﬁlament formation. This was
conﬁrmed by direct measurement of F actin/G actin ratio (Fig. 3D).
3.4. Cytochalasin D and Phalloidin treatment led to signiﬁcant changes in
OB differentiation in hMSCs.
siRNA-mediated knock down of CFL1 or DSTN in hMSCs increased
polymerized F-actin that was associated with enhanced OB differentia-
tion of hMSCs. To conﬁrm that increased levels of actin polymerization
exert signiﬁcant increase on the proliferation and OB differentiation of
hMSCs, we treated hMSCswith Cytochalsin D and Phalloidin. Cytochala-
sin D promotes depolymerizing actin and phalloidin stabilizes actin
ﬁlaments (Fig. S4). Treating hMSCs with Cytochalasin D inhibited
OB differentiation evidenced by a dose-dependent decrease in ALP
activity and decreased mineralized matrix formation (Fig. 4A). Con-
versely, Phalloidin treated hMSCs exhibited increased ALP activity and
mineralized matrix formation (Fig. 4B). The effects of Cytochalasin D
and Phalloidin on OB differentiation were also conﬁrmed in human
primary bone marrow MSCs (Fig. S5) and mouse bone marrow MSCs
(Fig. S6).
3.5. Inhibition of LIMK1 inhibited phosphorylation of Coﬁlin and OB
differentiation of hMSCs.
During the course of OB differentiation of hMSCs, phosphorylation of
Coﬁlin was up-regulated (Fig. 1) suggesting that phosphorylation of
Coﬁlin mediates changes in OB differentiation. Coﬁlin is inactivated by
the phosphorylation at Ser3 by LIM kinase (LIMK) and activated by
phosphatase SSH1. The spatially coordinated activities of LIMK and
Coﬁlin phosphatase are required for regulating actin dynamics and con-
trolling actin-dependent cellular processes (Yang et al., 1998). To exam-
ine whether the Coﬁlin phosphorylation loop plays a regulatory role in
Fig. 2. siRNA-mediated knockdown of CFL1 and DSTN enhanced osteoblast differentiation in vitro and heterotopic bone formation of hMSCs in vivo. Human stromal (skeletal)
stem cells (hMSCs) were cultured and transfected with siRNAs for CFL1, DSTN or with non-target siRNA (control). In vitro osteoblast (OB) differentiation: Twenty four hours
following transfection, the cells were induced to OB differentiation as described in Material & Methods. Cell viability (A), alkaline phosphatase (ALP) activity and ALP staining
(B) and mineralized matrix formation visualized by Alizarin red S (AZR) staining and quantitation (C) were performed. Results were presented as the mean ± standard error of
the mean (SEM) of at least three independent experiments. For in vivo heterotopic bone formation, siRNA-transfected cells were implanted coupled to hydroxyapatite/
tricalcium phosphate (HA/TCP) scaffold subcutaneously into immune deﬁcient NOD/SCID mice. (D) H&E staining was performed after 8 weeks of implantation to quantitate
newly formed bone. Bone tissue (red); HA/TCP scaffold (brown). Scale bar: 250 μm. (E) Bone formation was quantitated using image analysis and expressed as bone area divided
by total area (n = 7 implants per treatment). *P b 0.05; **P b 0.001.
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OB differentiation of hMSCs, we treated hMSC with LIMK inhibitor
(LIMKi). LIMK inhibitor reduced the phosphorylated Coﬁlin in a dose
dependent manner from 100 nM to 10 μM (Fig. 5A), and concomitantly
inhibited OB differentiation, as revealed by a dose-dependent decrease
in cell viability, ALP staining and activity, as well as a reduction in
mineralized matrix formation shown by Alizarin red (AZR) staining
Fig. 3. siRNA-mediated knockdown of CFL1 and DSTN increased polymerized actin (F-actin) levels but did not change cell morphology of human stromal (skeletal) stem cells (hMSCs).
hMSCs were cultured and transfected with siRNAs for CFL1, DSTN or with non-target siRNA (control). After 24 hours, the cells were stained with TRITC-Phalloidin and DAPI (A). Scale
bar: 100 μm. Analysis of changes of cell morphology was carried out by the Operetta® High Content Imaging System. Cell morphology and intensity of TRITC-Phalloidin binding actin
were analyzed by the Harmony® software (B & C). At the same time, transfected cells were harvested, cellular actin was separated by ultracentrifugation into F-actin and G-actin by
F-actin/G-actin in vivo assay kit. Quantitation of the ratio of F-actin and G-actin per total actin (%) was determined (D). Results are derived from at least three independent experiments.
Fig. 4. Cytochalsin D and Phalloidin treatment induced signiﬁcant changes in osteoblast OB differentiation of human stromal (skeletal) stem cells (hMSCs). hMSCs were induced to OB
differentiation, and the cells were treated with Cytochalasin D (1 hour, every other day) and Phalloidin (3 hours, every other day) at the indicated concentrations. Alkaline phosphtase
(ALP) staining was performed at OB differentiation Day 7. Alizarin red (AZR) staining was performed at OB differentiation Day 12. Data represents results from three independent
experiments. *P b 0.05, **P b 0.001.
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Fig. 5. Inhibition of LIMK reduced phosphorylation of Coﬁlin and inhibited osteoblast (OB) differentiation of hMSCs. Human bone marrow stromal (skeletal) stem cells (hMSCs) were
cultured and induced to OB differentiation. The cells were treated with a LIMK inhibitor (LIMKi) at the indicated concentrations for 14 days. (A) The phosphorylated Coﬁlin, total Coﬁlin,
and alpha-tubulin were measured by Western blot on OB differentiation Day 9. (B) Cell viability and alkaline phosphatase (ALP) activity were determined at OB differentiation Day 7.
(C) Staining for alkaline phosphatase was performed at OB differentiation Day 7 and for mineralized matrix formation by Alizarin red (AZR) were performed at OB differentiation Day
14. *P b 0.05, **P b 0.001. Data represents representational results from at least three independent experiments.
Fig. 6. Changes in actin polymerization led to alterations in cell viability and multiple intracellular signaling pathways. Human stromal (skeletal) stem cells (hMSCs) were cultured and
transfected with siRNAs for CFL1, DSTN, with non-target siRNA (control) (A), or treated with Phalloidin or Cytochalasin D in the indicated concentrations (B, C). Same amount cells
were seeding and induced to osteoblast (OB) differentiation as described in Material & Methods. (A) Cell numbers were determined during the OB differentiation on Day (D) 3, 6, and
9. (B, C) Cell viability was measured on day 7 in hMSCs treated with Phalloidin (3 hours each other day) or Cytochalsin D (1 hour each other day) during OB differentiation. (D) The
activation of intracellular signaling pathways (FAK, P38, JNK, Erk, Akt, Smad1/5/8) was analyzed by Western Blot analysis. Left part: hMSCs were transfected by siRNA for non-target
control, or CFL1 and DSTN. Right part: hMSCs were treated by Cytochalasin D (5 μM, 1 hour) or Phallodin (3 mM, 3 hours). Total cell lysates were subjected Western blot analysis. Data
represents representative result from at least three independent experiments.
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(Fig. 5B, C). siRNA-mediated knock down of LIMK1 in hMSCs led to sim-
ilar results (Fig. S7). We also checked the knockdown of phosphatase
SSH1 in hMSCs, but the knockdown of SSH1 in cells induced severe
cell death of hMSCs (data not shown).
3.6. Changes in actin dynamics affect cell viability
As mentioned above, change in actin dynamic assembly was associ-
ated with changes in cell viability. To further analyze this phenomenon,
we determined changes in the viable cells during the course of OB dif-
ferentiation. siRNA-mediated knock down of CFL1 or DSTN in hMSCs in-
creased the cell proliferation (Fig. 6A) suggesting that enhancing actin
polymerization improves cell survival. This notion was corroborated
by treating the cells with Cytochalasin D and Phalloidin. Cytochalasin
D reduced and Phalloidin increased the number of viable cells (Fig. 6B,
C). Similarly, LIMKi reduced viable cell numbers (Fig. 5B).
3.7. Changes in actin dynamics are associated with alterations in FAK, p38,
and JNK signalling
Since changes in actin dynamics affects hMSCs viability and differen-
tiation, we examined changes in a number of signaling pathways
known to be important in hMSCs biology.We detected increased activa-
tion of focal adhesion kinase (FAK), p38, and JNK kinases following
siRNA-mediated inhibition of CFL1 and DSTN expression and following
treatment with Phalloidin. The opposite effects were observed
following treatment with Cytochalasin D. We did not detect changes
in the activation at ERK, Akt, and Smad1/5/8 pathways (Fig. 6D)
4. Discussion
Actin cytoskeleton undergoes cycles of actin assembly that exists in
two states: a monomeric state (globular, G-actin) and a ﬁbrous state
(ﬁlamentous, F-actin). A variety of actin ﬁlament lengths and shapes
are established by actin-depolymerizing factors (ADFs) and other actin
binding factors that are responsible for changes in structure and mor-
phology of eukaryotic cells under different physiological conditions.
Among the ADFs, active Coﬁlin (non-phosphorylated) and DSTN bind
to F-actin without capping and severe the actin ﬁlament (F-actin) into
monomers free ends actin (G-actin). Polymerization of actin is regulat-
ed by a series of kinases, such as GTPase RhoA, RhoA kinase (ROCK), and
LIM kinases, which phosphorylates the actin depolymerizing protein
Coﬁlin and stabilizes actin ﬁlaments (Lodish et al., 2000). In the present
study, we demonstrated that changes in the levels of ADFs lead to
changes in viability and OB differentiation of hMSCs. siRNA-mediated
knocking down of CFL1 or DSTN enhanced OB differentiation and het-
erotopic bone formation of hMSCs in vivo. Our results conﬁrm part of
the ﬁndings in previous related studies (Rodriguez et al., 2004;
Sonowal et al., 2013), and fulﬁl the map where the balance of actin as-
sembly (depolymerization and polymerization) is a regulatory factor
for viability and OB differentiation of hMSCs and that these effects are
mediated through a number of intracellular signaling pathways (Fig. 7).
We observed that changes in actin dynamics induce alterations in cell
viability. A number of studies have indicated that factors regulating actin
cytoskeleton, can exert regulatory functions on cell proliferation. For ex-
ample, Coﬁlin phosphorylation mediates proliferation in response to
platelet-derived growth factor (PDGF) in rat aortic smooth muscle cells
(Won et al., 2008), and inhibition of Coﬁlin-1 expression blocks PDGF-
induced proliferation in endometrium (Wang et al., 2013). Conversely,
ectopic-expression of of ADFs and Coﬁlin suppress themotility and prolif-
eration of human lung cancer cells (Lee et al., 2005). These results suggest
that direct regulation of ADFs and actin reassembly can affect cell prolifer-
ation and viability. It is possible that ADFs and actin assembly can exert di-
rect regulation of cell cycle genes. It is also possible that actin reassembly
provide mechanical structure for cell division (Warn and Magrath, 1983;
Kaji et al., 2003) and the mitotic process (Tsai et al., 2009).
ADFs have been reported to regulate cell differentiation in a number
of tissues. CFL1 and DSTN are required for ureteric bud branching
morphogenesis (Kuure et al., 2010). Conditional deletion of CFL1 in neu-
ronal cells enhances cell differentiation (Bellenchi et al., 2007). In addi-
tion, Coﬁlin and phospho-Coﬁlin expression are increased in conditions
favoring myoﬁbroblast differentiation. Knockdown of CFL1 inhibited
collagen gel contraction and reduced myoﬁbroblast differentiation
(Pho et al., 2008). Moreover, CFL1 has been reported to be activated at
the time of podosome belt assembly during osteoclast differentiation
(Blangy et al., 2012). We report that ADFs participate in the regulation
of OB differentiation of hMSCs and provide a link between changes in
cytoskeleton and lineage speciﬁcation of hMSCs.
HumanDSTNandCFL1 aremore than 70% identical in amino acid se-
quence. DSTN has a much higher actin depolymerizing activity than
Coﬁlin (Yeoh et al., 2002) which is explained by sequence differences
at the F-actin-binding site (Pope et al., 2004). CFL1 deﬁciency is embry-
onic lethal at E11.5–12.5 and displays defects in neural tube closure and
neural crest cell migration despite high expression of DSTN (Gurniak
et al., 2005). DSTN deﬁcient mice are viable but have corneal defects
leading to eventual blindness in adult mice. Conversely, DSTN deﬁcient
micehave normal brain development (Ikeda et al., 2003).We found that
lowering both DSTN and CFL1 could enhance OB differentiation. How-
ever, part of DSTN’s effect on cell differentiation may be mediated
through enhancement of cell viability. The observed differences can be
caused by differences in binding afﬁnity with actin or actin depolymer-
ization efﬁciency. Further studies are needed to study these hypotheses.
In eukaryotic cells, Coﬁlin is an important dynamic regulator of actin
assembly. Its activity is regulated by phosphorylation at the N-terminal
Fig. 7. A working model illustrating the effect of changes in actin depolymerizing factors (ADFs) on cell viability and osteoblast differentiation of human stromal (skeletal) stem cells
(hMSCs). CFL: Coﬁlin; DSTN: Destrin; LIMK: LIM kinase; FAK: Focal adhesion kinase; p38: p38 mitogen-activated protein kinase; JNK: c-Jun N-terminal kinase.
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Serine 3 that inhibits its activity and the binding to G-actin. Dephosphor-
ylation at Ser-3 recovers CFL1 activity. LIM kinase (LIMK) is one of the
key kinases that regulate the activity of ADFs through phosphorylation
of the actin depolymerizing protein Coﬁlin (inactive Coﬁlin) thereby sta-
bilizing actin ﬁlament formation within the cell. In our study, inhibition
of LIMK by a chemical inhibitor or speciﬁc siRNA, resulted in inhibition
of activation and phosphorylation of Coﬁlin and inhibition of hMSCs via-
bility and OB differentiation. Our ﬁndings provide a molecular explana-
tion to previous observations of presence of low bone mass phenotype
in LIMK 1 deﬁcient mice (Kawano et al., 2013). In addition to LIMK1,
other upstream kinases are involved in the regulation of Coﬁlin phos-
phorylation and its activity. The Rho small GTPase family and its down-
stream effectors, Rho-associated kinase (ROCK) and p21-activated
kinase (PAK), can both phosphorylate activate LIMK and therefore inac-
tivate Coﬁlin (Zigmond, 1996; Bernard, 2007). Another kinase named
testis-speciﬁc kinase (TESK) can inactivate Coﬁlin through phosphoryla-
tion and is dependent on signaling through integrin (Toshima et al.,
2001). In contrast, slingshot (SSH) phosphatase and chronophin (CIN)
have been shown to activate Coﬁlin by dephosphorylating at Serine 3
residue and suppressing the assembly of actin ﬁlaments (Niwa et al.,
2002; Huang et al., 2006). Many studies have demonstrated that the
above mentioned kinases, such as Rho, Rac, Rock, LIMK and 14-3-3, are
possible regulators of OB differentiation (Liu et al., 2007; Yamashita
et al., 2008; Prowse et al., 2013). Our study suggest that these signaling
pathways can mediate their biological effects through changes in actin
cytoskeletal organization through conversion of ADFs and Coﬁlin in
cells and further signaling through FAK, JNK, and p38 MAP kinases sig-
naling pathways. Several studies have reported that themain actin bind-
ing proteins in vertebrate such as thymosin-beta 4 and proﬁlin regulate
cell differentiation, e.g. odontogenic differentiation or sternum develop-
ment (Lee et al., 2013; Someya et al., 2015) related to Akt, P38, JNK, ERK,
BMP pathways, followed by transcriptional regulation of Runx2 and
Osterix (Lee et al., 2013; Sonowal et al., 2013; Someya et al., 2015).
Since there exists over 60 families of actin-binding proteins that inﬂu-
ence actin ﬁlament assembly/disassembly, it will be very interesting to
explore the networks associated with actin assembly (composed by ki-
nases and actin binding proteins) during different lineage commitment
and differentiations of stem cells.
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